Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vascular contraction and relaxation mechanisms refer to the cellular and molecular signaling pathways that regulate the diameter and tone of blood vessels, predominantly through the activity of vascular smooth muscle cells. Contraction is primarily mediated by increases in intracellular calcium, activation of calmodulin, and subsequent phosphorylation of myosin light chains by myosin light chain kinase. Relaxation occurs through reductions in calcium levels, increased activity of myosin light chain phosphatase, and pathways mediated by cyclic nucleotides (cAMP, cGMP) activated by endothelium-derived factors such as nitric oxide and prostacyclin. These mechanisms are critical for blood pressure regulation and are central to the pathophysiology of various cardiovascular diseases[1][2][3][5].
Blocking calcium influx to induce vascular relaxation; Agonists/antagonists at adrenergic receptors to alter vascular tone; Increasing cGMP/cAMP to promote relaxation; Inhibiting myosin light chain kinase or activating myosin light chain phosphatase
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular smooth muscle contraction and relaxation mechanisms.